Atlas Trials

Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant

Clinical trial NCT01593215 · COMPLETED

Trial details

NCT number
NCT01593215
Sponsor
Anders Rosengren, MD PhD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2012-05-01
Primary completion
2014-10-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.